-
06:33:14 PM

ENTA Stock News

03/14/23 7:00 AM
Nasdaq : ENTA
conferencescovid-19low float
Enanta Pharmaceuticals to Present New Data for EDP-235, its 3CL Protease Inhibitor, in Development as an Oral, Once-Daily Treatment for COVID-19, at the 36th International Conference on Antiviral Research
Enanta Pharmaceuticals, Inc., a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections, today announced new data supporting the potential of EDP-235 for the treatment of COVID-19, which are being presented at the 36 th International Conference on Antiviral Research being held March 13-17, 2023 at the Centre...
RHEA-AI
positive
03/08/23 8:51 AM
Nasdaq : ENTA
conferencescovid-19low float
Enanta Pharmaceuticals to Present New Data for EDP-235, its 3CL Protease Inhibitor, in Development as an Oral, Once-Daily Treatment for COVID-19, at the 36th International Conference on Antiviral Research
Enanta Pharmaceuticals, Inc., a clinical stage biotechnology company dedicated to creating small molecule drugs for viral infections, today announced that data for EDP-235, its lead 3 CL protease inhibitor in development as an oral, once-daily treatment for COVID-19, will be presented at the 36th International Conference on Antiviral Research being held...
RHEA-AI
neutral
03/07/23 7:00 AM
Nasdaq : ENTA
conferenceslow float
Enanta Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare Conference
Enanta Pharmaceuticals, Inc., a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, will present at the Oppenheimer 33 rd Annual Healthcare Conference on March 14, 2023 at 10:00 a.m. ET. A live webcast of the event will be accessible...
RHEA-AI
neutral
02/07/23 4:01 PM
Nasdaq : ENTA
earningslow float
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2022 with Webcast and Conference Call Today at 4:30 p.m. ET
Enanta Pharmaceuticals, Inc., a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections, today reported financial results for its fiscal first quarter ended December 31, 2022. Notably, we are excited to make important progress in our COVID-19 program with the completion of enrollment in SPRINT, our Phase 2...
RHEA-AI
neutral
01/31/23 7:00 AM
Nasdaq : ENTA
conferencesearningslow float
Enanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss its Financial Results for Its Fiscal First Quarter Ended December 31, 2022
Enanta Pharmaceuticals, Inc., a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections, today announced that it plans to report its financial results for its fiscal first quarter ended December 31, 2022 after the U.S. market closes on February 7, 2023. Enanta management will host a conference call at 4:30 p.m....
RHEA-AI
neutral
01/06/23 7:00 AM
Nasdaq : ENTA
low float
Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 2023 Outlook at the 41st Annual J.P. Morgan Healthcare Conference
Enanta Pharmaceuticals, Inc., a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections, today announced that Jay R. Luly, Ph.D., Enanta’ s President and Chief Executive Officer, will provide an update across its pipeline of virology programs and plans for 2023 during Enanta’ s presentation at the 41 st Annual J.P....
RHEA-AI
neutral
01/03/23 7:00 AM
Nasdaq : ENTA
conferenceslow float
Enanta Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference
Enanta Pharmaceuticals, Inc., a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, will present at the 41 st Annual J.P. Morgan Healthcare Conference on January 10, 2023 at 3:00 p.m. PT. A live webcast of the presentation will be...
RHEA-AI
neutral
11/14/22 7:00 AM
Nasdaq : ENTA
conferencesearningslow float
Enanta Pharmaceuticals to Host Conference Call on November 21 at 4:30 p.m. ET to Discuss its Financial Results for Its Fiscal Fourth Quarter and Full Year Ended September 30, 2022
Enanta Pharmaceuticals, Inc., a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections, today announced that it plans to report its financial results for its fiscal fourth quarter and full year ended September 30, 2022 after the U.S. market closes on November 21, 2022. Enanta management will then host a...
RHEA-AI
neutral